Back to search
Esophageal Squamous Cell Cancer (SCC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Esophageal Squamous Cell Cancer (SCC) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Esophageal Squamous Cell Cancer (SCC) trials you may qualify forThis is a Phase Ib/II multi-center, open-label study of HMBD-001 in combination with cetuximab with or without docetaxel in participants with advanced Squamous…
The study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants wit…
The purpose of this first in human (FIH) trial was to characterize the safety and tolerability of the SHP2 inhibitor TNO155 alone and in combination with EGF816…
This study was a Phase Ib, multi-center, open-label study of TNO155 in combination with spartalizumab or ribociclib with a dose escalation part followed by a do…